| Name | Title | Contact Details |
|---|
GTESS Corporation is a Richardson, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Headquartered in Louisville, KY, Trilogy Health Services was founded in December 1997 and is dedicated to being the Best Healthcare Company in the Midwest by providing exceptional, comprehensive care to seniors in our living communities. Trilogy has over 100 locations and continues to grow across IN, OH, MI and KY. Join our growing company and experience the Trilogy Difference.
Nicka and Associates, Inc is a Plano, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the world. Under a number of NBTY and third party brands, the Company offers over 22,000 products, including products marketed by the Company`s Nature`s Bounty® (www.NaturesBounty.com), Vitamin World® (www.VitaminWorld.com), Puritan`s Pride® (www.Puritan.com), Holland and Barrett® (www.HollandAndBarrett.com), Rexall® (www.Rexall.com), Sundown® (www.Sundownnutrition.com), MET-Rx® (www.MetRX.com), WORLDWIDE Sport Nutrition® (www.SportNutrition.com), American Health® (www.AmericanHealthUS.com), GNC (UK)® (www.GNC.co.uk), DeTuinen® (www.DeTuinen.nl), LeNaturiste (www.LeNaturiste.com), SISU® (www.SISU.com), Solgar® (www.Solgar.com) and Ester-C® (www.Ester-C.com) brands.
Mr. Gallagher is Senior Vice President & Chief Financial Officer at RRD International, LLC. Mr. Gallagher provides strategic, operational, and financial leadership to RRD. His primary responsibilities are planning, implementing, managing, and controlling all financial-related activities including the development of financial and operational strategies. Mr. Gallagher has over 20 years of finance experience in the biopharma industry with both multi-national corporations and commercial-stage public biotechnology companies. He has an extensive background in all areas of corporate controllership, including financial planning & analysis, cost control, management accounting, corporate administration, and systems implementation. He has supported all aspects of product development and commercialization, including the negotiation and execution of licensing and collaboration agreements with major pharma partners. Mr. Gallagher served previously as Vice President of Finance for Optimer Pharmaceuticals and, prior to that, as Senior Director of Finance and Corporate Controller for Adolor Corporation. He had a central role in the sale of both companies. Mr. Gallagher spent the first 10 years of his career with Therakos, Inc. (a Johnson & Johnson company) and Merck & Co., Inc. He received his BS in Finance from The Pennsylvania State University and is an active Certified Management Accountant (CMA).